Ocular diseases such as glaucoma, macular degeneration, and diabetic retinopathy demand precise and sustained drug delivery for therapeutic efficacy. Traditional methods face significant challenges, including poor drug bioavailability due to tear dilution, blinking, and limited tissue permeability. These barriers highlight the need for innovative solutions that enhance therapeutic outcomes and patient compliance. Smart drug delivery systems have emerged as promising alternatives, enabling targeted and controlled release of drugs to specific ocular tissues.
Key approaches include using nanoparticles, hydrogels, and polymeric systems, with smart materials like pH-sensitive and temperature-responsive polymers offering tailored responses to ocular conditions. pH-sensitive polymers, such as poly(acrylic acid), chitosan, and methacrylic acid copolymers, react to pH changes caused by inflammation or infection, releasing drugs accordingly. Temperature-responsive polymers, like PNIPAAm and PEG-based copolymers, exploit ocular surface temperature variations during inflammation or infection to achieve controlled release. These systems show potential for improving drug efficacy, reducing side effects, and enhancing patient adherence. However, a comprehensive evaluation of their efficacy, safety, and applicability across various ocular diseases is needed.
This project aims to develop innovative, biocompatible, and biodegradable smart drug delivery systems to address the limitations of conventional treatments. Stimuli-responsive nanoparticles and hydrogels will be engineered for sustained and targeted drug release. Advanced techniques, including 3D printing, microneedles, and imaging, will be employed for system design and characterisation. Preclinical evaluations using animal models and excised ocular tissues will assess their translational potential. Expected outcomes include improved ocular bioavailability, prolonged drug retention, and enhanced patient compliance, paving the way for advanced therapeutic strategies for debilitating eye conditions. This research could significantly improve the management of ocular diseases by overcoming current drug delivery challenges.
References
Lin, X., Wu, X., Chen, X., Wang, B. and Xu, W., (2021) Intellective and stimuli-responsive drug delivery systems in eyes. International Journal of Pharmaceutics, 602, p.120591.
Dahmash, E. Z.; Achkar, N. R.; Ali, D. K.; Jarrar, Q.; Iyire, A.; Assaf, S. M.; Alyami, H. (2024) Preclinical evaluation of novel synthesised nanoparticles based on tyrosine poly (ester amide) for improved targeted pulmonary delivery. Scientific Reports 14(1):9845
Alotaibi, T. A.; Iyire, A; Assaf, S; Dahmash. E. Z. (2024) Development and characterization of niosomes loaded mucoadhesive biodegradable ocular inserts for extended release of pilocarpine HCl. Future Journal of Pharmaceutical Sciences 10(1):22